129 related articles for article (PubMed ID: 11004567)
1. Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.
Haga A; Niinaka Y; Raz A
Biochim Biophys Acta; 2000 Jul; 1480(1-2):235-44. PubMed ID: 11004567
[TBL] [Abstract][Full Text] [Related]
2. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
Niinaka Y; Paku S; Haga A; Watanabe H; Raz A
Cancer Res; 1998 Jun; 58(12):2667-74. PubMed ID: 9635595
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
[TBL] [Abstract][Full Text] [Related]
4. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
5. Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Timár J; Tóth S; Tóvári J; Paku S; Raz A
Clin Exp Metastasis; 1999; 17(10):809-16. PubMed ID: 11089878
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Yanagawa T; Funasaka T; Tsutsumi S; Raz T; Tanaka N; Raz A
J Biol Chem; 2005 Mar; 280(11):10419-26. PubMed ID: 15637053
[TBL] [Abstract][Full Text] [Related]
7. [Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm].
Haga A
Yakugaku Zasshi; 2005 Feb; 125(2):169-75. PubMed ID: 15684571
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta.
Yanagawa T; Watanabe H; Takeuchi T; Fujimoto S; Kurihara H; Takagishi K
Lab Invest; 2004 Apr; 84(4):513-22. PubMed ID: 14968121
[TBL] [Abstract][Full Text] [Related]
9. The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Haga A; Tanaka N; Funasaka T; Hashimoto K; Nakamura KT; Watanabe H; Raz A; Nagase H
J Mol Biol; 2006 May; 358(3):741-53. PubMed ID: 16563432
[TBL] [Abstract][Full Text] [Related]
10. Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
Lagana A; Duchaine T; Raz A; DesGroseillers L; Nabi IR
Biochem Biophys Res Commun; 2000 Jun; 273(1):213-8. PubMed ID: 10873589
[TBL] [Abstract][Full Text] [Related]
11. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
[TBL] [Abstract][Full Text] [Related]
12. Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.
Tanaka N; Haga A; Uemura H; Akiyama H; Funasaka T; Nagase H; Raz A; Nakamura KT
J Mol Biol; 2002 May; 318(4):985-97. PubMed ID: 12054796
[TBL] [Abstract][Full Text] [Related]
13. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.
Chaput M; Claes V; Portetelle D; Cludts I; Cravador A; Burny A; Gras H; Tartar A
Nature; 1988 Mar; 332(6163):454-5. PubMed ID: 3352744
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin.
Sun YJ; Chou CC; Chen WS; Wu RT; Meng M; Hsiao CD
Proc Natl Acad Sci U S A; 1999 May; 96(10):5412-7. PubMed ID: 10318897
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Yanagawa T; Funasaka T; Tsutsumi S; Hu H; Watanabe H; Raz A
Cancer Res; 2007 Sep; 67(18):8682-9. PubMed ID: 17875708
[TBL] [Abstract][Full Text] [Related]
16. The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function.
Tsutsumi S; Gupta SK; Hogan V; Tanaka N; Nakamura KT; Nabi IR; Raz A
FEBS Lett; 2003 Jan; 534(1-3):49-53. PubMed ID: 12527360
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of neuroleukin in osseous tissues and its involvement in mineralization during osteoblast differentiation.
Zhi J; Sommerfeldt DW; Rubin CT; Hadjiargyrou M
J Bone Miner Res; 2001 Nov; 16(11):1994-2004. PubMed ID: 11697795
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognition.
Chou CC; Sun YJ; Meng M; Hsiao CD
J Biol Chem; 2000 Jul; 275(30):23154-60. PubMed ID: 10770936
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a lysyl aminopeptidase activity associated with phosphoglucose isomerase of Vibrio vulnificus.
Richards GP; Hammer CH; Garfield MK; Parveen S
Biochim Biophys Acta; 2004 Aug; 1700(2):219-29. PubMed ID: 15262231
[TBL] [Abstract][Full Text] [Related]
20. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
